Raffles Medical Group Ltd (SGX:BSL)
Singapore
· Delayed Price · Currency is SGD 1.010
+0.010 (1.00%)
Mar 10, 2026, 10:37 AM SGT
Raffles Medical Group Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,840 | 1,877 | 1,579 | 2,006 | 2,595 | 2,560 | Upgrade
|
| Market Cap Growth | 12.54% | 18.84% | -21.25% | -22.73% | 1.40% | 37.98% | Upgrade
|
| Enterprise Value | 1,619 | 1,647 | 1,387 | 1,814 | 2,498 | 2,571 | Upgrade
|
| Last Close Price | 1.00 | 1.02 | 0.83 | 1.03 | 1.30 | 1.24 | Upgrade
|
| PE Ratio | 26.25 | 26.60 | 25.38 | 22.25 | 18.12 | 30.41 | Upgrade
|
| Forward PE | 25.43 | 25.69 | 21.36 | 21.39 | 24.52 | 45.67 | Upgrade
|
| PS Ratio | 2.40 | 2.45 | 2.10 | 2.83 | 3.15 | 3.53 | Upgrade
|
| PB Ratio | 1.74 | 1.78 | 1.48 | 1.92 | 2.53 | 2.62 | Upgrade
|
| P/TBV Ratio | 1.76 | 1.80 | 1.53 | 1.99 | 2.62 | 2.76 | Upgrade
|
| P/FCF Ratio | 19.69 | 20.08 | 23.58 | 11.88 | 15.16 | 23.23 | Upgrade
|
| P/OCF Ratio | 18.16 | 18.52 | 18.31 | 10.59 | 13.23 | 15.99 | Upgrade
|
| PEG Ratio | 3.77 | - | - | - | 2.23 | - | Upgrade
|
| EV/Sales Ratio | 2.12 | 2.15 | 1.84 | 2.56 | 3.03 | 3.55 | Upgrade
|
| EV/EBITDA Ratio | 12.19 | 12.39 | 12.05 | 13.65 | 10.42 | 17.94 | Upgrade
|
| EV/EBIT Ratio | 17.86 | 18.16 | 16.31 | 16.76 | 11.72 | 21.75 | Upgrade
|
| EV/FCF Ratio | 17.33 | 17.62 | 20.71 | 10.75 | 14.59 | 23.34 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.09 | 0.09 | 0.12 | 0.13 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 0.70 | 0.70 | 0.73 | 0.86 | 0.51 | 1.51 | Upgrade
|
| Debt / FCF Ratio | 0.99 | 0.99 | 1.38 | 0.74 | 0.75 | 2.13 | Upgrade
|
| Net Debt / Equity Ratio | -0.21 | -0.21 | -0.24 | -0.21 | -0.12 | -0.03 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.64 | -1.64 | -2.18 | -1.65 | -0.52 | -0.21 | Upgrade
|
| Net Debt / FCF Ratio | -2.33 | -2.33 | -3.75 | -1.30 | -0.72 | -0.28 | Upgrade
|
| Asset Turnover | 0.52 | 0.52 | 0.49 | 0.46 | 0.54 | 0.49 | Upgrade
|
| Inventory Turnover | 37.98 | 37.98 | 35.60 | 30.68 | 32.10 | 37.93 | Upgrade
|
| Quick Ratio | 1.27 | 1.27 | 1.32 | 1.25 | 1.33 | 1.02 | Upgrade
|
| Current Ratio | 1.31 | 1.31 | 1.35 | 1.28 | 1.36 | 1.05 | Upgrade
|
| Return on Equity (ROE) | 6.70% | 6.70% | 5.91% | 8.79% | 14.31% | 8.85% | Upgrade
|
| Return on Assets (ROA) | 3.83% | 3.83% | 3.48% | 4.42% | 8.66% | 5.01% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.22% | 8.34% | 7.44% | 9.54% | 17.28% | 9.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.30% | 8.30% | 7.40% | 9.40% | 18.20% | 10.50% | Upgrade
|
| Earnings Yield | 3.83% | 3.76% | 3.94% | 4.50% | 5.52% | 3.29% | Upgrade
|
| FCF Yield | 5.08% | 4.98% | 4.24% | 8.42% | 6.60% | 4.30% | Upgrade
|
| Dividend Yield | 2.91% | 2.94% | 3.01% | 2.33% | 2.93% | 1.45% | Upgrade
|
| Payout Ratio | 65.57% | 65.57% | 71.62% | 78.41% | 36.32% | 44.37% | Upgrade
|
| Buyback Yield / Dilution | 0.36% | 0.36% | 0.41% | -0.12% | 0.54% | -1.96% | Upgrade
|
| Total Shareholder Return | 3.28% | 3.31% | 3.43% | 2.21% | 3.46% | -0.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.